HIV Working Group Releases Report On Vaccine, Microbicide Research, Development

Main Category: HIV / AIDS
Also Included In: Immune System / Vaccines
Article Date: 06 Dec 2007 - 6:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

"Building a Comprehensive Response: Funding for HIV Vaccines, Microbicides and Other New Preventive Options: 2000 to 2006," HIV Vaccine and Microbicides Resource Tracking Working Group: The report provides estimates of investment in HIV vaccine and microbicide research and development from 2000 to 2006. The report also includes estimates of investment in new prevention options -- including male circumcision, suppression of the genital herpes virus HSV-2, cervical barriers and pre-exposure prophylaxis.

The report found that over the seven year period, public and philanthropic funding for HIV vaccine and microbicide research and development almost tripled. In 2006, total global investment in preventive HIV vaccine research and development was about $933 million -- a 23% increase compared with 2005 funding levels. For microbicide research and development during the same year, worldwide investment was about $222 million -- a 35% increase compared with 2005. Between 2000 and 2006, five public-sector funders and two foundations provided $183.6 million for research and development in support of new prevention options, the report found. The report added that financial needs for research and development will "remain substantial in the coming years" ("Building a Comprehensive Response: Funding for HIV Vaccines, Microbicides and Other New Preventive Options: 2000 to 2006," November 2007).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved